Genetics Investing

Adaptimmune Therapeutics Receives Orphan Drug Designation

Biotech Investing

Magenta Therapeutics Wins RMAT from FDA for Cell Therapy Drug

Biotech Investing

Krystal Biotech Initiates Phase 1/2 Study of KB105

Genetics Investing

Lineage Cell Therapeutics Announces Data From Vision Restoration Program

Genetics Investing

Adaptimmune and Noile-Immune to Develop SPEAR T-Cell Products

Biotech Investing

Mustang Bio Announces License Agreement with CSL Behring

Biotech Investing

Sarepta Therapeutics Receives FDA Rejection, Shares Dip

Genetics Investing

Cancer Genetics Reports Q2 Financial Results

Genetics Investing

Myriad Genetics Tumbles on Fiscal Q4 and 2019 Results

Genetics Investing

Sarepta Dips on “Erroneous” Report to FDA

Biotech Investing

Applied DNA Signs Master Services Agreement with Schreiner Group

Genetics Investing

Applied DNA Signs Agreemnet with Montblanc-Simplo GMBH

Genetics Investing

Latest genetics News

More genetics News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES
×